Taiho Pharmaceutical Company
Taiho Pharmaceutical Co., Ltd. is a pharmaceutical company based in Tokyo, Japan, established in June 1963. The company specializes in the research, development, production, distribution, and marketing of pharmaceutical products, with a strong focus on oncology. Taiho develops a range of cancer treatments, including S-1 for gastric cancer and TAS-102 for colorectal cancer. In addition to oncology drugs, the company also produces controlled medical devices and various classes of over-the-counter medications. Through its commitment to developing innovative therapies, Taiho aims to improve the lives of patients and support healthcare professionals in oncology and other medical fields.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.